Every year, a vast number of new antibodies appears on the market. Most of them come from hybridoma which are in possession of academic laboratories. These laboratories are wishing to increase the value of their research products.

Marketing your antibodies

BIOTEM proposes to evaluate the commercial potential of your antibodies.

If marketing your antibodies is an option, our team can then produce, characterise and market the batches generated thanks to our international distribution network. Royalties are then paid to the owner of the product.

Joint-development

BIOTEM is actively seeking new partners to jointly develop projects (antibody generation, immunoassay kit development, etc.).

In such collaborations, BIOTEM and its partners agree to share development expenses as well as to allocate fairly the profits arising from sales

Do not hesitate to contact our business development department: learn more...